ストックスクリーナーアプリを入手
3.695
0.67%
-0.025
前日終値:
$3.72
開ける：
$3.75
24時間の取引高:
1.79M
Relative Volume:
0.97
時価総額：
$463.60M
収益：
$50.27M
当期純損益:
$-68.91M
株価収益率:
-6.1277
EPS:
-0.603
ネットキャッシュフロー:
$-44.32M
1週間 パフォーマンス:
+0.41%
1か月 パフォーマンス:
-11.18%
6か月 パフォーマンス:
+25.25%
1年 パフォーマンス:
-3.78%
1日の値動き範囲:
$3.605
$3.78
1週間の範囲:
$3.56
$3.86
52週間の値動き範囲:
$2.93
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
名前
Aquestive Therapeutics Inc
セクター
電話
908-941-1900
住所
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
3.695 | 467.99M | 50.27M | -68.91M | -44.32M | -0.603 |
TAK
Takeda Pharmaceutical Co Adr
|
17.10 | 55.69B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.855 | 43.77B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.01 | 36.19B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.28 | 32.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
517.71 | 26.29B | 3.17B | 1.29B | 1.01B | 27.09 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-24 | 再開されました | Oppenheimer | Outperform |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2024-12-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Piper Sandler | Overweight |
| 2024-03-28 | 開始されました | Raymond James | Outperform |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-04-22 | 開始されました | H.C. Wainwright | Buy |
| 2019-01-03 | 開始されました | Lake Street | Buy |
| 2018-08-20 | 開始されました | JMP Securities | Mkt Outperform |
| 2018-08-20 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Aquestive Therapeutics Inc (AQST) 最新ニュース
Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Investors to Inquire about Securities Investigation - ACCESS Newswire
Aquestive Therapeutics Inc (AQST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aquestive Therapeutics Inc (AQST) Institutional Confidence - TradingKey
AQST|Aquestive Therapeutics Inc|Price:3.680|Chg%:-0.090 - TradingKey
Aquestive Therapeutics Inc (AQST) Balance Sheet - TradingKey
2026-07-26 | Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Investors to Inquire about Securities Investigation | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics Inc (AQST) Cash Flow - TradingKey
Aquestive Therapeutics Inc (AQST) Income Statement - TradingKey
Aquestive Therapeutics Inc (AQST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Shareholders to Connect - ACCESS Newswire
ETFs Investing in Aquestive Therapeutics, Inc. Stocks - TradingView
Aquestive Therapeutics Inc (AQST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aquestive Therapeutics, Inc. (AQST) And Encourages Shareholders to Reach Out - ACCESS Newswire
2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Shareholders to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse
Price to book forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView
Enterprise value to EBITDA forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView
Price to sales forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView
Enterprise value to revenue forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView
Form 4 Aquestive Therapeutics Inc For: 17 July By Investing.com - Investing.com South Africa
Insider Sell: Aquestive Therapeutics Inc (AQST) President and CE - GuruFocus
Aquestive Therapeutics president and CEO Daniel Barber sells $100,191 in stock - Investing.com Canada
Aquestive Therapeutics (AQST) CEO Barber sells 25,000 shares between $4.00 and $4.04 - Stock Titan
Aquestive Therapeutics CEO Daniel Barber disposes of 25,000 common shares worth $100,201.97 - Bitget
Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Aquestive Therapeutics, Inc. (AQST) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gew - The National Law Review
2026-07-16 | Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse
Enterprise value to EBIT forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, I - The National Law Review
Form 144 Aquestive Therapeutics For: 15 July By Investing.com - Investing.com South Africa
Price to earnings forward of Aquestive Therapeutics, Inc. – NASDAQ:AQST - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2026-07-14 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Investors to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Aquestive Therapeutics (AQST) Faces Selling Pressure, Tests Support Near $3.91Cash Flow Strong Stocks - dars.gov.et
2026-07-12 | Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Investors to Connect - ACCESS Newswire
Aquestive Therapeutics, Inc. SEC Filing (Jul 9, 2026) - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism - Investing News Network
Aquestive Therapeutics to present at Leerink Pa... - Pluang
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
2026-07-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Investors to Learn More About the Investigation | NDAQ:AQST | Press Release - Stockhouse
AQSTAquestive Therapeutics Inc Short Interest - Finviz
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Stockholders to Connect - ACCESS Newswire
AQST News | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aquestive Therapeutics, Inc. (AQST) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Aquestive Therapeutics Inc (AQST) 財務データ
収益
当期純利益
現金流量
EPS
Aquestive Therapeutics Inc (AQST) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Barber Daniel | President and CEO |
Jul 15 '26 |
Sale |
4.03 |
4,631 |
18,683 |
630,943 |
2.08%
0.17%
大文字化:
|
ボリューム (24 時間):